Baird (investment bank) & Jefferies
5 shared events · Importance 3 · Last updated Jul 23, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Baird (investment bank): Baird (investment bank) is acting as a bookrunning manager for the offering, contributing to the syndicate of underwriters.
Jefferies: Jefferies is acting as a joint lead bookrunning manager for the offering, contributing to the successful placement of shares.
Jun 01, 2026 · 8 articles
Business
Baird (investment bank): Baird (investment bank) is acting as lead manager for the public offering by Taysha Gene Therapies.
Jefferies: Jefferies is acting as a joint book-running manager for the public offering by Taysha Gene Therapies.
Jun 24, 2026 · 10 articles
Business
Baird (investment bank): Baird (investment bank) is acting as a lead manager for the public offering by Enliven Therapeutics.
Jefferies: Jefferies is acting as a joint book-running manager for the public offering by Enliven Therapeutics, facilitating the sale of securities.
Jun 11, 2026 · 7 articles
Regulatory
Baird (investment bank): Baird (investment bank) is a financial services firm that slashed Immutep's price target and downgraded its stock to Neutral after the trial failure, indicating a loss of confidence in the company's future.
Jefferies: Jefferies is an investment bank that downgraded Immutep's stock to Hold following the TACTI-004 trial discontinuation, reflecting the market's negative reaction.
May 18, 2026 · 158 articles
Business
Baird (investment bank): Baird (investment bank)>>> acted as a financial advisor for Novanta>>> in this acquisition.
Jefferies: Jefferies>>> acted as the sole financial advisor for Riverpoint Medical>>> in this transaction.
Jun 09, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Baird (investment bank) and Jefferies interact across events, view sentiment trends, and discover connected entities.
Open Dashboard